The G11778A LHON mutation does not enhance ethambutol cytotoxicity in a cybrid model

Clinical Neuropathology

Volumn 27, Issue 6, 2008, Pages 414-423

  Pommer, R ^a   Schoeler, S ^a   Mawrin, C ^b   Szibor, R ^a   Kirches, Elmar ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

ATP; Cybrid; Ethambutol; LHON; mtDNA

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ANTIBIOTIC AGENT; ETHAMBUTOL; MITOCHONDRIAL DNA;

ARTICLE; CELL LINE; CELL SURVIVAL; CONTROLLED STUDY; CYBRID; CYTOTOXICITY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA REPLICATION; ENERGY YIELD; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; LEBER HEREDITARY OPTIC NEUROPATHY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TERATOMA;

EID: 57149094678     PISSN: 07225091     EISSN: None     Source Type: Journal    
DOI: 10.5414/npp27414     Document Type: Article

References (30)

1. Baracca A, Solaini G, Sgarbi G, Lenaz G, Baruzzi A, Schapira AHV, Martinuzzi A, Carelli V. Severe impairment of complex I-driven adenosine, triphosphate synthesis in Leber hereditary optic neuropathy cybrids. Arch Neurol. 2005; 62: 730-736.
2. Beretta S, Mattavelli L, Sala G, Tremolizzo L, Schapira AHV, Martinuzzi A, Carelli V, Ferrarese C. Leber hereditary optic neuropathy mtDNA mutations disrupt glutamate transport in cybrid cell lines. Brain. 2004; 127: 2183-2192.
3. Brown MD, Trounce IA, Jun AS, Akken JC, Wallace DC. Functional analysis of lymphoblasts and cybrid mitochondria containing the 3460,11778 or 14484 Leber's hereditary optic neuropathy mitochondrial DNA mutations. J Biol Chem. 2000; 275: 39831-39836.
4. Carelli V, Ghelli A, Bucchi L, Montagna P, De Negri A, Leuzzi V, Carducci C, Lenaz G, Lugaresi E, Degli Eposti M. Biochemical features of mtDNA 14484 (ND6/M64V) point mutation associated with Leber's hereditary optic neuropathy. Ann Neurol. 1999; 45: 320-328.
5. Carelli V, Rugolo M, Sgarbi G, Ghelli A, Zanna C, Baracca A, Lenaz G, Napoli E, Martinuzzi A, Solaini G. Bioenergetics shapes cellular death pathways in Leber's hereditary optic neuropathy: a model of mitochondrial neurodegeneration. Biochem Biophys Acta. 2004a; 1658: 172-179.
6. Carelli V, Ross-Cisneros FN, Sadun AA. Mitochondrial dysfunction as a cause of optic neuropathies. Prog Retin Eye Res. 2004b; 23: 53-89.
7. Floreani M, Napoli E, Martinuzzi A, Pantano G, De Riva V, Trevisan R, Bisetto E, Valente L, Carellio V, Dabbeni-Sala F. Antioxidant defence in cybrids harboring mtDNA mutations associated with Leber's hereditary optic neuropathy. FEBS J. 2005; 272: 1124-1135.
8. Fraunfelder FW, Sadun AA, Wood T. Update of ethambutol optic neuropathy. Exp Opin Drug Saf. 2006; 5: 615-618.
9. von Graefe A. Ein urigewöhnlicher Fall von hereditärer Amaurose. Arch Ophthalmol. 1858; 266-268.
10. Haroon MF, Fatima A, Scholer S, Gieseler A, Horn TF, Kirches E, Wolf G, Kreutzmann P. Minocycline, a possible neuroprotective agent in Leber's hereditary optic neuropathy (LHON): studies of cybrid cells bearing 11778 mutation. Neurobiol Dis. 2007; 28: 237-250.
11. Heng JE, Vorwerk CK, Lessell E, Zurakovsky D, Levin LA, Dreyer EB. Ethambutol is toxic to retinal ganglion cells via an excitotoxic pathway. IOVS. 1999; 40: 190-196.
12. Hudson G, Keers S, Yu Wai Man P, Griffiths P, Huoponen K, Savontaus ML, Nikoskelainen E, Zeviani M, Carrara F, Horvath R, Karcagi V, Spruijt L, de Coo IF, Smeets HJ, Chinnery PF. Identification of an X-chromosomal locus and haplotype modulating the phenotype of a mitochondrial DNA disorder. Am J Hum Genet. 2005; 77: 1086-1091.
13. Hwang JM, Kim J, Park SS. Leber hereditary optic neuropathy mutations in ethambutol optic neuropathy. J Neurol. 2003; 250: 87-89.
14. Ikeda A, Ikeda T, Ikeda N, Kawakami Y, Mimura O. Leber's hereditary optic neuropathy precipitated by ethambutol. Jpn J Ophthalmol. 2006; 50: 280-283.
15. Leber T. Über hereditäre und congenital angelegte Sehnervenleiden. Arch Ophthalmol. 1871; 17: 249-291.
16. Lee CS, Gambertoglio JG, Brater DC, Benet LZ. Kinetics of oral ethambutol in the normal subject. Clin Pharmacol Ther. 1977; 22: 615-621.
17. Mackey DA, Buttery RG. Leber hereditary optic neuropathy in Australia. Aust N Z J Ophthalmol. 1992; 20: 177-184.
18. Majander A, Finel M, Savontaus ML, Nikoskelainen E, Wikstrom M. Catalytic activity of complex I in cell lines that possess replacement mutations in the ND genes in Leber's hereditary optic neuropathy. Eur J Biochem. 1996; 239: 201-207.
19. Man PY, Griffiths PG, Brown DT, Howell N, Turnbull DM, Vhinnery PF. The epidemiology of Leber hereditary optic neuropathy in the North East of England. Am J Hum Genet. 2003; 72: 333-339.
20. Peets EA, Sweeny WM, Place VA, Buyske DA. The absorption, excretion and metabolic fate of ethambutol in man. Am Rev Respir Dis. 1965; 91: 51-58.
21. Pleasure SJ, Page C, Lee VM. Pure, postmitotic, polarized human neurons derived from NTera 2 cells provide a system for expressing exogeneous proteins in terminally differentiated neurons. J Neurosci. 1992; 12: 1802-1815.
22. Sadun AA, Carelli V, Salomao SR, Berezosky A, Quiros P, Sadun F, DeNegri AM, Andrade R, Schein S, Belfort R. A very large Brazilian pedigree with 11778 Leber's hereditary optic neuropathy. Trans Am Ophthalmol Soc. 2002: 169-178.
23. Sadun AA, Carelli V, Salomao SR, Berezovsky A, Quiros PA, Sadun F, DeNegri AM, Andrade R, Moraes M, Passos A, Kjaer P, Pereira J, Valentino ML, Schein S, Belfort R. Extensive investigation of a large Brasilian pedigree pf 11778/haplogroup J Leber hereditary optic neuropathy. Am J Ophthalmol. 2003; 136: 231-238.
24. Sadun F, DeNegri AM, Carelli V, Salomao SR, Berezovsky A, Andrade R, Moraes M, Passos A, Belfort R, da Rosa AB, Quiros P, Sudan AA. Ophthalmologic findings in a large pedigree of 11778/Haplogroup J Leber hereditary optic neuropathy. Am J Ophthalmol. 2004: 271-277.
25. Schoeler S, Winkler-Stuck K, Szibor R, Haroon MF, Gellerich FN, Chamaon K, Mawrin C, Kirches E. Glutathione depletion in antioxidant defense of differentiated NT2-LHON cybrids. Neurobiol Dis. 2007; 25: 536-544.
26. Wallace DC, Singh G, Lott MT, Hodge JA, Schurr TG, Lezza AM, Nikoskelainen EK. Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science. 1988; 242: 1427-1430.
27. Wong A, Cavalier L, Collins-Schramm HE, Seldin MF, McGrogan M, Savontaus ML, Cortopassi GA. Differentiation-specific effects of LHON mutations introduced into neuronal NT2 cells. Hum Mol Genet. 2002; 11: 431-438.
28. Yoon YH, Jung KH, Sadun AA, Shin HC, Koh JY. Ethambutol-induced vacuolar changes and neuronal loss in rat ganglion cell culture: mediation by endogeneous zinc. Toxicol Appl Pharmacol. 2000; 162: 107-114.
29. Zanna C. Ghelli A, Porcelli AM, Carelli V, Martinuzzi A, Rugolo M. Apoptotic cell death of cybrid cells bearing Leber's hereditary optic neuropathy mutations is caspase-independent. Ann N Y Acad Sci. 2003; 1010: 213-217.
30. Zanna C, Ghelli A, Porcelli AM, Martinuzzi A, Carelli V, Rugolo M. Caspase-independent death of Leber's hereditary optic neuropathy cybrids is driven by energetic failure and mediated by AIF and endonuclease G. Apoptosis. 2005; 10: 997-1007.